Norfoalk - Crunchbase Company Profile & Funding

Overview

Norfoalk

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Norfoalk

Norfoalk is Investment Management company at Lyon.

Private

Key People

Jean-Guillaume Lafay: Chief Executive Officer and Founder
Past Role: Mablink Bioscience, CEO & Co-Founder

Details

Operating Status

Active

Founders

Jean-Guillaume Lafay

Investor Type

obfuscation

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Investments

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation
obfuscated obfuscation	Axoltis Pharma	—	Series A - Axoltis Pharma	obfuscated obfuscation

Market Intelligence

People

View Profiles & Contacts

Employee Profiles

Jean-Guillaume Lafay Chief Executive Officer and Founder

News

News and Press

News•

Dec 5, 2025

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Dec 3, 2025

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Dec 2, 2025

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Dec 2, 2025

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

Access a complete feed of recent news and press, from product launches to leadership changes.

Technology

View Tech Report

Lists Featuring This Company

Private Equity Firms with Investments in European Union (EU)

2,859 Number of Organizations • $139.6B Total Funding Amount • 688 Number of Investors

Investors Active in Lyon, Rhone-Alpes

463 Number of Organizations • $41B Total Funding Amount • 228 Number of Investors

Claude Bernard University Lyon 1 Alumni Founded Companies

139 Number of Organizations • $4.1B Total Funding Amount • 180 Number of Investors

Investors Active in Rhone-Alpes

966 Number of Organizations • $180.8B Total Funding Amount • 487 Number of Investors

Sub-Organizations

Frequently Asked Questions